Correlation between Serum Malondialdehyde levels and prevalence of cardiovascular disease in Haemodialysis treated patients

被引:2
|
作者
Rehman, Sadia [1 ]
Mahboob, Tabassum [2 ]
Kamali, Muhammad Farhan [2 ]
机构
[1] Bahria Univ, Med & Dent Coll, Dept Biochem, Karachi, Pakistan
[2] Univ Karachi, Dept Biochem, Karachi, Pakistan
关键词
Malondialdehyde; Haemodialysis; Cardiovascular disease; Oxidative stress; Free radicals; INTIMA-MEDIA THICKNESS; CHRONIC-RENAL-FAILURE; OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; OXIDIZED LDL; ASSOCIATION; ANTIOXIDANTS;
D O I
10.47391/JPMA.4402
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To investigate the role of serum malondialdehyde as a diagnostic biomarker of free radical production and cardiovascular disease in patients treated with maintenance haemodialysis. Method: The case-control study was conducted in the Department of Biochemistry, Basic Medical Sciences Institute (BMSI) of the Jinnah Postgraduate Medical Centre (JPMC), Karachi, and the JPMC Nephrology ward from January 12, 2018, to January 15, 2019, and comprised patients receiving haemodialysis as the cases and healthy controls. Blood samples were obtained from all the subjects for checking the level of serum malondialdehyde. Doppler ultrasonography was employed to detect the intima media thickness ratio of the common carotid artery of all the subjects. Data ws analysed using SPSS 23. Results: Of the 90 subjects, 45(50%) each were cases and controls. There were significant differences in mean values related to age, body mass index and blood pressure between the groups. A statistically significant rise was seen in serum malondialdehyde and carotid artery intima media thickness ratio in the cases compared to the controls (p<0.05). Conclusion: Serum malondialdehyde was found to be significantly raised in haemodialysis patients compared to the healthy controls.
引用
收藏
页码:1577 / 1580
页数:4
相关论文
共 50 条
  • [1] Relationship between serum CHIP levels with cardiovascular disease in maintenance haemodialysis patients
    Xu, Taijing
    Liu, Mengjun
    Zhao, Xinhui
    Zhang, Shenglei
    Ma, Shuchen
    Wang, Jun
    Wang, Yi
    Guo, Yide
    Wang, He
    Hong, Xuan
    Liu, Feng
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2023, 50 (06) : 527 - 538
  • [2] Exploring the correlation between periodontal disease and serum biomarkers in haemodialysis patients
    Basha, Maimona Mansour
    Al-Kadasi, Baleegh Abdulraoof
    Al-Hajri, Manal
    Al-Sharani, Hesham Mohammed
    Elayah, Sadam Ahmed
    [J]. BMC ORAL HEALTH, 2024, 24 (01):
  • [3] Correlation between malondialdehyde levels and disease activity in vitiligo
    Sudarsa, Prima Sanjiwani Saraswati
    Praharsini, I. Gusti Ayu Agung
    Karna, Ratih Vibriyanti
    [J]. BALI MEDICAL JOURNAL, 2020, 9 (03) : 677 - 680
  • [4] Correlation of Serum Magnesium and Malondialdehyde Levels in Patients with Myocardial Infarction
    Kamath, Suhasini
    Varashree, B. S.
    John, Pamala
    Mohapatra, Nirupam
    Shenoy, Revathi P.
    Shetty, Ranjan
    [J]. RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2016, 7 (05): : 791 - 795
  • [5] SERUM SCLEROSTIN LEVELS IN HAEMODIALYSIS PATIENTS AND THEIR CORRELATION WITH THE INFLAMMATORY STATE
    Tartaglione, Lida
    Pasquali, Marzia
    Rotondi, Silverio
    Muci, Maria Luisa
    Leonangeli, Cristiana
    Mazzaferro, Sandro
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [6] Correlation of Serum Adropin Levels with Risk Factors of Cardiovascular Disease in Hemodialysis Patients
    Liu, Feng
    Cui, Binbin
    Zhao, Xinhui
    Wu, Yanfen
    Qin, Huan
    Guo, Yide
    Wang, He
    Lu, Mingjie
    Zhang, Shenglei
    Shen, Jie
    Shi, Xiaoling
    Liang, Weiwei
    Ma, Shuchen
    Li, Qing
    Zhu, Aiguo
    Qi, Hualin
    [J]. METABOLIC SYNDROME AND RELATED DISORDERS, 2021, 19 (07) : 401 - 408
  • [7] Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis
    Boaz, M
    Matas, Z
    Biro, A
    Katzir, Z
    Green, M
    Fainaru, M
    Smetana, S
    [J]. KIDNEY INTERNATIONAL, 1999, 56 (03) : 1078 - 1083
  • [8] The association between serum irisin levels and cardiovascular disease in diabetic patients
    Khorasani, Zahra Mazloum
    Bagheri, Ramin Khameneh
    Yaghoubi, Mohammad Ali
    Chobkar, Saeed
    Aghaee, Monavvar Afzal
    Abbaszadegan, Mohammad Reza
    Sahebkar, Amirhossein
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (01) : 786 - 790
  • [9] DECREASE OF SERUM MALONDIALDEHYDE IN PATIENTS TREATED WITH CHLORPROMAZINE
    BINDOLI, A
    RIGOBELLO, MP
    CAVALLINI, L
    DALLALIBERA, A
    GALZIGNA, L
    [J]. CLINICA CHIMICA ACTA, 1987, 169 (2-3) : 329 - 332
  • [10] Serum apolipoprotein at (ApoA1) levels are strong predictors of atherosclerotic cardiovascular disease in patients on chronic haemodialysis
    Kirmizis, D
    Tsiandoulas, A
    Koutoupa, E
    Pangalou, M
    Rozi, P
    Protopappa, M
    Barboutis, K
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 157 - 158